top of page
Latest News from Pro PG


Pro PG receives S19 A for Bleomycin Injection (market shortage Australia) - stock available now.
Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.
Apr 20, 2019
bottom of page